Maurice Beghetti

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


14 publications

 
Impact of Liver Diseases on Heart and Lungs.
Hachulla A.L., Rautou P.E., Franchi-Abella S., Lagadec M., Mueller H., Noble S., Bouchardy J., Lambert V., Lador F., Beghetti M. et al. JACC. Cardiovascular imaging. Peer-reviewed.
 
Effects of PDE-5 Inhibition on the Cardiopulmonary System After 2 or 4 Weeks of Chronic Hypoxia.
Nydegger C., Corno A.F., von Segesser L.K., Beghetti M., Samaja M., Milano G., 2019/08. Cardiovascular drugs and therapy, 33 (4) pp. 407-414. Peer-reviewed.
 
Early Diagnosis in Pulmonary Arterial Hypertension: The Search for the Holy Grail.
Berger RMF, Beghetti M., 2019/06/01. American journal of respiratory and critical care medicine, 199 (11) pp. 1306-1307. Peer-reviewed.
Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study.
Beghetti M., Channick R.N., Chin K.M., Di Scala L., Gaine S., Ghofrani H.A., Hoeper M.M., Lang I.M., McLaughlin V.V., Preiss R. et al., 2019/03. European journal of heart failure, 21 (3) pp. 352-359. Peer-reviewed.
 
An update on current and emerging treatments for pulmonary arterial hypertension in childhood and adolescence.
Wacker J., Weintraub R., Beghetti M., 2019/02. Expert review of respiratory medicine, 13 (2) pp. 205-215. Peer-reviewed.
Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
Gatzoulis M.A., Landzberg M., Beghetti M., Berger R.M., Efficace M., Gesang S., He J., Papadakis K., Pulido T., Galiè N. et al., 2019/01/02. Circulation, 139 (1) pp. 51-63. Peer-reviewed.
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management.
Rosenzweig E.B., Abman S.H., Adatia I., Beghetti M., Bonnet D., Haworth S., Ivy D.D., Berger RMF, 2019/01. The European respiratory journal, 53 (1). Peer-reviewed.
 
Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls.
Farhat N., Cools B., Gewillig M., Seghaye M.C., Aggoun Y., Beghetti M., 2019. Frontiers in pediatrics, 7 p. 262. Peer-reviewed.
 
Regression of Advanced Liver Fibrosis After Heart Transplantation in a Patient With Prior Fontan Surgery for Complex Congenital Heart Disease.
Bouchardy J., Meyer P., Yerly P., Blanche C., Hullin R., Giostra E., Hanquinet S., Rubbia-Brandt L., Sekarski N., Prêtre R. et al., 2018/11. Circulation. Heart failure, 11 (11) pp. e003754. Peer-reviewed.
 
Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension.
Blanche C., Alonso-Gonzalez R., Uribarri A., Kempny A., Swan L., Price L., Wort S.J., Beghetti M., Dimopoulos K., 2018/09/15. International journal of cardiology, 267 pp. 79-83. Peer-reviewed.
A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE-3.
Berger RMF, Gehin M., Beghetti M., Ivy D., Kusic-Pajic A., Cornelisse P., Grill S., Bonnet D., FUTURE-3 investigators, 2017/08. British journal of clinical pharmacology, 83 (8) pp. 1734-1744. Peer-reviewed.
Adapting the "Chester step test" to predict peak oxygen uptake in children.
Maggio ABR, Vuistiner P., Crettenand A., Tabin R., Martin X.E., Beghetti M., Farpour-Lambert N.J., Deriaz O., 2017/06/21. Swiss medical weekly, 147 pp. w14435. Peer-reviewed.
Echocardiographic Evaluation of Pulmonary Pressures and Right Ventricular Function after Pediatric Cardiac Surgery: A Simple Approach for the Intensivist.
Beghetti M., 2017. Frontiers in pediatrics, 5 p. 184. Peer-reviewed.
 
Yasui procedure.
Myers P., Sologashvili T., Wacker J., Vallée J.P., Beghetti M., Prêtre R., 2016/12/09. Multimedia manual of cardiothoracic surgery : MMCTS, 2016 p. 0. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University